台股 » 聿新科 » 個股財報 » 稅後淨利成長率(季增率)
- 股價
32.70
- 漲跌
▼0.05
- 漲幅
-0.15%
- 成交量
19張
- 產業
上櫃 生技醫療類股
▼0.42%
-
本地時間:13:30
聿新科 (4161) 財務報表－稅後淨利成長率(季增率)
稅後淨利成長率
稅後淨利季增率 = (稅後淨利÷上季稅後淨利)-1。
稅後淨利年增率 = (稅後淨利÷去年同季稅後淨利)-1。
聿新科 (4161) 稅後淨利季增率與季收盤價比較圖
聿新科 (4161) 歷年稅後淨利季增率
| 年度/季別 | 稅後淨利季增率 | 近4季稅後淨利季增率 | 年度/季別 | 稅後淨利季增率 | 近4季稅後淨利季增率 |
|---|
| 2024Q3 | -37.83% | -11.89% | 2021Q3 | 178.7% | -97.91% |
| 2024Q2 | 61.18% | 17.6% | 2021Q2 | 145.52% | -22.15% |
| 2024Q1 | -49.04% | 12.58% | 2021Q1 | -109.28% | -26.36% |
| 2023Q4 | 11.86% | 27.98% | 2020Q4 | -31.22% | 13.26% |
| 2023Q3 | 163.87% | 3.9% | 2020Q3 | 283.3% | 124.5% |
| 2023Q2 | 66.79% | 21.14% | 2020Q2 | -57.29% | 70.15% |
| 2023Q1 | -56.55% | 11.66% | 2020Q1 | 57.35% | -119933.3% |
| 2022Q4 | -43.17% | 32.92% | 2019Q4 | -253.26% | -99.7% |
| 2022Q3 | 4188.29% | 102.95% | 2019Q3 | 64.32% | -118.28% |
| 2022Q2 | -57.61% | -15.27% | 2019Q2 | -921.71% | -208.52% |
| 2022Q1 | -65.72% | 0.1% | 2019Q1 | -91.65% | -11.82% |
| 2021Q4 | -56.82% | -2855.36% | | | |
聿新科首創「血壓、血糖、膽固醇」三高機Anue鉅亨－2022/08/29
聿新科:聿新生物科技股份有限公司資本公積配發股東現金股利公告Anue鉅亨－2020/08/12
聿新科7月營收0.50億元年增17.79% 1—7月達2.90億元Anue鉅亨－2020/08/04